3.- RIDUZIONE DEL DANNO

Neufeld K., Kidorf M., King V., Stoller K., Clark M., Peirce J., Brooner R., Using enhanced and integrated services to improve response to standard methadone treatment: Changing the clinical infrastructure of treatment networks, Substance Abuse Treatment, 2010; 38 (2): 170 – 177

Pollack H., D’Aunno T., Dosage patterns in methadone treatment: Results from a national survey, 1988 – 2005., Health Services Research, 2008; 43 (6): 2143 – 2163

Nair M., Patel K., Starer P., Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient, Addiction, 2008; 103 (12): 2062 – 2064

McMillan G., Lapham S., Lackey M., The effect of a jail methadone maintenance therapy (MMT) program on inmate recidivism, Addiction, 2008; 103 (12): 2017 – 2023

Hedrich D., Pirona A., Wiessing L., From margin to mainstream: The evolution of harm reduction responses to problem drug use in Europe, Drugs - Education Prevention and Policy, 2008; 15 (6): 503 – 517

Dunn K., Sigmon S., McGee M., Heil S., Higgins S., Evaluation of ongoing oxycodone abuse among methadone-maintained patients, Journal of Substance Abuse Treatment, 2008; 35 (4): 451 - 456.

Deering D., Sellman J., Adamson S., Horn J, Frampton C., Development of a Brief Treatment Instrument for Routine Clinical Use with Methadone Maintenance Treatment Clients: The Methadone Treatment Index, Substance Use & Misuse, 2008; 43 (11): 1666 – 1680

Eksborg S., Rajs J., Causes and manners of death among users of heroin, methadone, amphetamine, and cannabis in relation to postmortem chemical tests for illegal drugs, Substance Use & Misuse, 2008; 43 (10): 1326 – 1339

Roche A., McCabe S., Smyth B., Illicit methadone use and abuse in young people accessing treatment for opiate dependence, European Addiction Research, 2008; 14 (4): 219 - 225

Ross D., Lo F., McKim R., Allan M., A primary care/multidisciplinary harm reduction clinic including opiate bridging, Substance Use & Misuse, 2008; 43 (11): 1628 – 1639

Roux P., Carrieri M., Villes V., Dellamonica P., Poizot-Martin I., Ravaux I., et al., The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study, Addiction, 2008; 103 (11): 1828 - 1836

Wu LT., Blazer D., Stitzer M., Patkar A., Blaine J., Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study, The American Journal on Addictions, 2008; 17 (4):304 – 311

Gordon M., Kinlock T., Schwartz R., o'Grady K., A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release, Addiction, 2008; 103 (8): 1333 – 1342

Nordt C., Stohler R., Estimating heroin epidemics with data of patients in methadone maintenance treatment, collected during a single treatment day, Addiction, 2008; 103 (4): 591 – 597

Kleinig J., The ethics of harm reduction, Substance Use & Misuse, 2008; 43 (1): 1 – 16

Christie T., Groarke L., Sweet W., Virtue ethics as an alternative to deontological and consequential reasoning in the harm reduction debate, The international Journal of Drug Policy, 2008; 19 (1): 52 – 58

McKeganey N., Safe injecting rooms and evidence based drug policy, Drugs Education Prevention and Policy, 2006; 13 (1): 1-3

Fry C., Cvetkovski S., Cameron J., The place of supervised injecting facilities within harm reduction: evidence, ethics and policy, Addiction, 2006; 101 (4): 465-467

Schifano P., Bargagli A. M., Belleudi V., Amato L., Davoli M., Diecidue R., et al. Methadone treatment in clinical practice in Italy: need for improvement, European Addiction Research, 2006; 12 (3): 121-127

Rowe J., Laying the foundations: addressing heroin use among the street homeless, Drugs Education Prevention and Policy, 2006; 12 (1): 47-59

Williams N., Nasir R., Smither G., Troon S., Providing opioid substitution treatment indigenous heroin users within a community health service setting in Adelaide, Drug and Alcohol Review, 2006; 25 (3): 227-232

Reading B., What’s the matter with methadone? Addiction Research and Theory, 2005; 13 (6): 591-592

Bloor, M., Neale J., McKeganey N., Persisting local variations in prevalence of hepatitis C virus among Scottish problem drug users: results from an anonymous screening study, Drugs Education Prevention and Policy, 2006; 13 (2): 189-191

Hopwood M., Treloar C., Bryant J., Hepatitis C and injectingrelated discrimination in New South Wales, Australia, Drugs Education Prevention and Policy, 2006; 13 (2): 201-203

Craig L., Applied ethical reflections on the operation of a Geneva drug consumption room: opportunities for enhanced harm reduction practice, International Journal of Drug Policy, 2006; 17 (1): 1-2

Scott B., Harm reduction: what’s lawyer to do? International Journal of Drug Policy, 2006; 17 (1): 47-50

Skretting A., The Nordic countries and public drug-injection facilities, Education Prevention & Policy, 2006; 13 (1): 5-16

McNeely J., Arnsten J., Gourevitch M., Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey, Harm Reduction Journal, 2006; 3 (8): 1-6

Phillips C., Guenzel B., Bergen P., Deconstructing anti-harmreduction metaphors; mortality risk from falls and other traumatic injuries compared to smokeless tobacco use, Harm Reduction Journal, 2006; 3 (15): 1-5

Degenhardt L., Black E., Breen C., Bruno R., Kinner S., Roxburgh A.,et al. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia, Drug and Alcohol Review, 2006; 25 (5): 403-412

Amundsen E., Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users, Addiction, 2006; 101 (7): 911-912

Rhodes T., Kimber J., Small W., Fitzgerald J., Kerr T., Hickman M., et al. Public injecting and the need for ‘safer environment interventions’ in the reduction of drug-related harm, Addiction, 2006; 101 (10): 1384-1393

Loumakou M., Brouskeli V., Sarafidou J., Aiming at tobacco harm reduction : a survey comparing smokers differing in readiness to quit, Harm Reduction Journal, 2006; 3 (13): 1-6

Worthington N., Piper T., Galea S., Rosenthal D., Opiate users’ knowledge about overdose prevention and naloxone in New York City: a focus group study, Harm Reduction Journal, 2006; 3 (19): 1-19

McKeganey N., Abstinence and harm reduction: two roads to one destination?, Drugs Education Prevention and Policy, 2006; 12 (4): 251-253

Uitemark J., Cohen P., Amphetamine users in Amsterdam: patterns of use and models of self-regulation, Addiction Research and Theory, 2006; 14 (2): 159-188

Tompkins C., Sheard L., Wright N., Jones L., Howes N., Exchange, deceit, risk and harm: the consequences for women of received injections from other drug users, Drugs Education Prevention and Policy, 2006; 13 (3): 281-297

Mooney G., We still need communitarian ethics in harm reduction research, Drug and Alcohol Review, 2006; 25 (4): 373-374

Higgs P., Moore D., Aitken C., Engagement, reciprocity and advocacy: ethical harm reduction practice in research with injecting drug users, Drug and Alcohol Review, 2006; 25 (5): 419- 424

Costenbader E., Astone N., Latkin C., The dynamics of injection drug users’ personal networks and HIV risk behaviours, Addiction, 2006; 101 (7): 1003-1014

Klaw E., Horst D., Humphreys K., Inquirers, triers, and buyers of an alcohol harm reduction self-help organization, Addiction Research and Theory, 2006; 14 (5): 527-536

Allman D., Myers T., Schellenberg F., Strike C., Cockerill R., Cavalieri W., Peer networking for the reduction of drug-related harm, The International Journal of Drug Policy, 2006; 17 (5): 402-410

Strathdee A., Pollini A., Miller L., Palmer E., Malta M., Azim T., Remembering the past, rebuilding the future: a summary of the 17th International Conference on the Reduction of Drug Related Harm, Vancouver, Canada, 2006

McKeganey N., Morris Z., Neal J., Michele R., Comment on “’what are drug users looking for when they contact drug services: abstinence or harm reduction?, Drugs Education Prevention and Policy, 2005; 12 (4): 255-256